“…In this context, improvement in tactile appreciation of the size, number and location of the tumour(s) during RARP may prove useful. Early reports of preoperative threedimensional (3D)-printing technology in urological surgery have focused on proof of concept, face and content validity [4,5]. We report an Idea, Development, Exploration, Assessment, Long-term follow-up (IDEAL) Phase 2a study [6] of the use of patient-specific 3D printing in RARP.In all, 10 patients with localised T3 prostate cancer either clinically or on pre-biopsy multiparametric MRI, subsequently treated with RARP, were included in this prospective pilot study after ethics approval, patient consent, and discussion at the regional multidisciplinary team meeting.Patient-specific geometries were segmented from MRI data.…”